# Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

> **NCT04768465** · — · UNKNOWN · sponsor: **Da, Yuwei, M.D.** · enrollment: 160 (estimated)

## Conditions studied

- Myasthenia Gravis

## Interventions

- **DRUG:** Pyridostigmine, Prednisone, Tacrolimus
- **DRUG:** Pyridostigmine, Tacrolimus

## Key facts

- **NCT ID:** NCT04768465
- **Lead sponsor:** Da, Yuwei, M.D.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768465, "Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04768465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*